Skip to main content
Fig. 5 | Cardiovascular Diabetology

Fig. 5

From: SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice

Fig. 5

Triglyceride levels and steatotic count. Triglycerides levels in liver tissue in treated (n = 18) compared to untreated (n = 19) ob/ob−/− group (a). Steatosis score in treated (n = 12) compared to untreated (n = 10) ob/ob−/− group (b). Data were analyzed using two-tailed Mann–Whitney test for liver triglycerides and t-test for steatosis score and are presented as mean with standard deviation. ‡p ≤ 0.05 represents significant difference between ob/ob−/− treated and untreated group

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840